about
γ-Glutamyltransferase, but not markers of hepatic fibrosis, is associated with cardiovascular disease in older people with type 2 diabetes mellitus: the Edinburgh Type 2 Diabetes StudyPopulation genomics of cardiometabolic traits: design of the University College London-London School of Hygiene and Tropical Medicine-Edinburgh-Bristol (UCLEB) ConsortiumAssociation between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.Morning cortisol levels and cognitive abilities in people with type 2 diabetes: the Edinburgh type 2 diabetes study.Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes.Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes StudyAssociation of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetes.Reproductive history and chronic hepatic steatosis in the Michigan Study of Women's Health Across the NationPrevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes StudyCardiovascular risk factors and cognitive decline in older people with type 2 diabetes.Glucocorticoid treatment and impaired mood, memory and metabolism in people with diabetes: the Edinburgh Type 2 Diabetes Study.Clinically significant chronic liver disease in people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study.Clinical and subclinical macrovascular disease as predictors of cognitive decline in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.The relationship between diabetic retinopathy and cognitive impairmentRacial/ethnic differences in hepatic steatosis in a population-based cohort of post-menopausal women: the Michigan Study of Women's Health Across the Nation.Association between excessive daytime sleepiness and severe hypoglycemia in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes StudyElevated fasting plasma cortisol is associated with ischemic heart disease and its risk factors in people with type 2 diabetes: the Edinburgh type 2 diabetes study.Cognitive function, dementia and type 2 diabetes mellitus in the elderly.Nick Hales Award Lecture 2011: glucocorticoids and early life programming of cardiometabolic disease.Association of retinal arteriolar dilatation with lower verbal memory: the Edinburgh Type 2 Diabetes Study.Comparison of non-traditional biomarkers, and combinations of biomarkers, for vascular risk prediction in people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study.Variation in the uric acid transporter gene (SLC2A9) and memory performance.Hepatic steatosis and non-alcoholic fatty liver disease are not associated with decline in renal function in people with Type 2 diabetes.Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes study.N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.R D Lawrence Lecture 2010. The brain as a target organ in Type 2 diabetes: exploring the links with cognitive impairment and dementia.Severe hypoglycaemia and late-life cognitive ability in older people with Type 2 diabetes: the Edinburgh Type 2 Diabetes Study.Genetic Associations Between Fibrinogen and Cognitive Performance in Three Scottish Cohorts
P2860
Q28648219-255F1754-E171-4CDC-8DF7-FC8278940CBCQ28681745-E30BDDF7-BD83-43FD-85D6-BE5165FE7E86Q33688605-6AC8AAFB-820A-48C0-BD13-BC212B672787Q33751423-1A944DB1-F228-419C-B35F-967871C8FD76Q33854492-7B328843-DCEA-4D50-ABD6-B8F29C77AA5FQ34237709-3935C755-DBCA-482A-9D1B-A4904995C9CDQ34413727-C3B9A24E-BDD8-4843-A827-AF38E4A2A10AQ34999722-65EBA35F-FE94-4806-B13B-A76311B7CE61Q35043760-5D4D0701-F924-4B17-8E6D-CA94E106BDF8Q35757186-115AC9C0-2941-4A75-A25D-BF9826831AC9Q35926504-254C39A1-8870-4D97-92F5-46238C4B2144Q36750183-2E97E757-D9BD-471B-BA92-3C4A7C8075CFQ37106524-00FAB2F6-81D1-4AF2-ABE5-4E6A7797C476Q37193439-C98B2E2E-67A6-481F-A636-66755BEF901DQ37204875-714437F0-A147-4C35-B9B3-9AB9B9C0A6A8Q37331174-351DBAB0-535B-46C9-B6DD-4643DA688B47Q37655205-59D3B3B1-6335-4CF8-987E-348F28367828Q37677063-34A5DE13-278F-4D15-A30B-50D5C662DA73Q37832122-CA5502CA-AB97-4266-9FFE-66E4EF9B3EB5Q38237780-20BFDDAD-5981-4E99-8E20-00FC616F5BCEQ39977422-0D5C4F44-27FA-48D4-9186-85904BEDA06BQ40094602-BCFB7690-EEFC-437A-879C-0E4006953D43Q43144722-D036FDD9-514E-49EB-AB0F-3DE98D090741Q44682506-6D54FE89-4CED-4F67-BBB5-4EA3D89E50A6Q45402850-0D8814D2-0768-4012-B2B8-A2502606BFA7Q48535643-D6853E68-9C75-477F-B37F-935356D5B600Q48541090-F15ED4BF-4E50-4567-A937-A4930D09EE7DQ50604282-CD450DD1-B80A-41EC-B632-6DB0068FAE1FQ56993555-6F56CB6F-F384-4631-9359-61D390D8809B
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The Edinburgh Type 2 Diabetes Study: study protocol.
@ast
The Edinburgh Type 2 Diabetes Study: study protocol.
@en
type
label
The Edinburgh Type 2 Diabetes Study: study protocol.
@ast
The Edinburgh Type 2 Diabetes Study: study protocol.
@en
prefLabel
The Edinburgh Type 2 Diabetes Study: study protocol.
@ast
The Edinburgh Type 2 Diabetes Study: study protocol.
@en
P2093
P2860
P356
P1476
The Edinburgh Type 2 Diabetes Study: study protocol.
@en
P2093
Amanda J Lee
Brian M Frier
F Gerald R Fowkes
Ian J Deary
Jackie F Price
Mark W J Strachan
Peter C Hayes
Rachel M Williamson
Rebecca M Reynolds
Rory J Mitchell
P2860
P2888
P356
10.1186/1472-6823-8-18
P577
2008-12-11T00:00:00Z
P5875
P6179
1034549874